Company Description: PHIOGEN is a spin-off from Baylor College of Medicine and was born out of innovation from the globally renowned team at TAILOR Labs, one of the US’s only bacteriophage therapy centers, built on over a decade’s worth of research, now being commercialized to combat the AMR infection crisis. PHIOGEN’s proprietary first-of-its-kind technology platform is developing these bacteria-eating viruses at scale, singling out those with elite bacteria-fighting abilities, and evolving phage into antimicrobials which overcome resistance. By optimizing nature’s defenders, our team has produced phages which have been safely and successfully administered to patients in FDA approved compassionate use cases and are being prepared for wide-scale clinical trials.